• ABG leads Pulmonx's $65 million financing biospectrumasia
    May 12, 2019
    Pulmonx is the latest example of ABG's focus on investing in cutting-edge technologies run by best-in-class management teams
  • OSSIO secures $22 M in Financing biospectrumasia
    March 12, 2019
    OSSIO, a US based orthopedic fixation company has announced the closing of $22 million in equity financings led by OCV Partners, a Los Angeles based venture capital firm, with continued participation from existing investors Ortho Vision LLC and Secocha Ve
  • Knight Therapeutics invests up to $125m in Latin America-focused Moksha8 pharmaceutical-technology
    February 20, 2019
    Canada-based Knight Therapeutics has announced it has closed a strategic financing agreement of up to $125m with US-headquartered Moksha8....
  • Impel raises $67.5M as it eyes filing for nasal migraine drug fiercebiotech
    December 29, 2018
    Impel NeuroPharma’s championing of the nasal delivery route for drugs has been rewarded with a fourth-round financing that will help it advance three projects through the clinic.....
  • Impel NeuroPharma Closes $67.5 Million Series D Financing firstwordpharma
    December 06, 2018
    Impel NeuroPharma ("Impel" or the "Company"), a Seattle-based, privately-held biotechnology company focused on developing therapies for the treatment of central nervous system ("CNS") disorders with unmet medical needs, today announced that it has complet
  • Oncology Analytics raises $21M Series B financing led by Oak HC/FT biospectrumasia
    November 07, 2018
    Prominent healthcare investor Oak HC/FT joined by McKesson Ventures, Blue Cross Blue Shield Venture Partners and Sandbox Advantage Fund to Accelerate Patient-First Oncology Benefits Management
  • Verana Health Announces $30M Series C Financing biospectrumasia
    October 25, 2018
    Company also announces seasoned healthcare executive Miki Kapoor as CEO to develop leading specialty data platform
  • Holmusk secures $9.75 M in Pre-Series A financing biospectrumasia
    October 25, 2018
    The funds allow Holmusk to expand its footprint in USA and Europe.Image credit- marsdd.com Holmusk, a Singapore-headquartered digital health and data analytics company with a global presence, recently announced closing of $9.75 million in Pre-Series A
  • Jinxin Fertility announces completion of major financing round biospectrum
    October 11, 2018
    With its outstanding competitive edges, Jinxin Fertility has become a rare privately-owned assisted reproductive institution in China that is able to compete with the best local public hospitals and even take a leading position in the field.
  • ANTABIO Completes € 12.5M Series A b3cnewswire
    July 24, 2018
    New investors Omnes, BNP Paribas Développement and Sham Innovation Santé invest an additional €5.2M on top of the €7.3M first closing announced in October 2017
PharmaSources Customer Service